Download PDF
Thromb Haemost 1992; 68(03): 341-345
DOI: 10.1055/s-0038-1656377
Original Article
Schattauer GmbH Stuttgart

Mass Contents of Inositol 1,4,5-Trisphosphate and 1,2-Diacylglycerol in Human Platelets Stimulated with a Thromboxane Analogue and Thrombin

A Suganuma
1   The Department of Drug Safety Research, Eisai Co., Ltd., Gifu, Japan
,
S Nakashima
The Department of Biochemistry, Gifu University School of Medicine, Gifu, Japan
,
Y Okano
The Department of Biochemistry, Gifu University School of Medicine, Gifu, Japan
,
Y Nozawa
The Department of Biochemistry, Gifu University School of Medicine, Gifu, Japan
› Author Affiliations
Further Information

Publication History

Received 13 December 1991

Accepted after revision 09 April 1992

Publication Date:
04 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

Mass contents of inositol 1,4,5-trisphosphate (IP3) and 1,2-diacylglycerol (DG) were measured in U46619-stimulated human platelets. 1 µM of U46619 induced maximum responses in aggregation, 5-hydroxytryptamine (5HT) secretion and increase in intracellular free Ca2+ concentration ([Ca2+]i). Aggregation was almost comparable to that induced by maximal dose (1 U/ml) of thrombin, while 5HT release was almost half. The initial [Ca2+]i peak in response to U46619 was about half of thrombin stimulation. Production of IP3 and DG was, however, less than one tenth of that seen in thrombin stimulation. The profile (time course and concentration-dependency) of IP3 formation did not correlate with that of [Ca2+]i, suggesting that U46619 stimulates IPs-dependent and -independent Ca2+ mobilization. DG production was small but sustained for more than 5 min. These findings support the recent hypothesis that aggregation is regulated by a delayed accumulation of DG. The low level of 5HT secretion could be explained by the low production of second messengers, IP3 and DG.

 

  • References

  • 1 Armstrong RA, Jones RL, Wilson NH. Ligand binding to thromboxane receptors on human platelets: correlation with biological activity. Br J Pharmacol 1983; 79: 953-964
    CrossrefPubMedGoogle Scholar
  • 2 Morinelli TA, Niewiarowski S, Daniel JL, Smith JB. Receptor-mediated effects of a PGH2 analogue (U46619) on human platelets. Am J Physiol 1987; 253: H1035-H1043
    PubMedGoogle Scholar
  • 3 Pollock WK, Armstrong RA, Brydon LJ, Jones RL, MacIntyre DE. Thromboxane-induced phosphatidate formation in human platelets. Relationship to receptor occupancy and to changes in cytosolic free calcium. Biochem J 1984; 219: 833-842
    PubMedGoogle Scholar
  • 4 Siess W, Boehlig B, Weber PC, Lapetina EG. Prostaglandin endoperoxide analogues stimulate phospholipase C and protein phosphorylation during platelet shape change. Blood 1985; 65: 1141-1148
    PubMedGoogle Scholar
  • 5 Brass LF, Shaller CC, Belmonte EJ. Inositol 1,4,5-trisphosphate-induced granule secretion in platelets. Evidence that the activation of phospholipase C mediated by platelet thromboxane receptors involves a guanine nucleotide binding protein-dependent mechanism distinct from that of thrombin. J Clin Invest 1987; 79: 1269-1275
    PubMedGoogle Scholar
  • 6 Kawahara Y, Fukuzaki H, Kaibuchi K, Tsuda T, Hoshijima M, Takai Y. Activation of protein kinase C by the action of 9,11-epithio-11,12-methano-thromboxane A2 (STA2), a stable analogue of thromboxane A2, in human platelets. Thromb Res 1986; 41: 811-818
    CrossrefPubMedGoogle Scholar
  • 7 Palmer S, Hughes KT, Lee DY, Wakelam MJO. Development of a novel, Ins(1,4,5)P3-specific binding assay, Its use to determine the intracellular concentration of Ins(1,4,5)P3 in unstimulated and vasopressin-stimulated rat hepatocytes. Cell Signalling 1989; 1: 147-156
    CrossrefPubMedGoogle Scholar
  • 8 Preiss J, Loomis CR, Bishop WR, Stein R, Niedel JE, Bell RM. Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes, and ras- and sis-transformed normal rat kidney cells. J Biol Chem 1986; 261: 8597-8600
    PubMedGoogle Scholar
  • 9 Nakashima S, Suganuma A, Matsui A, Nozawa Y. Thrombin induces a biphasic 1,2-diacylglycerol production in human platelets. Biochem J 1991; 275: 355-361
    CrossrefPubMedGoogle Scholar
  • 10 Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature (London) 1962; 194: 927-929
    PubMedGoogle Scholar
  • 11 Nakashima S, Tohmatsu T, Hattori H, Okano Y, Nozawa Y. Inhibitory action of cyclic GMP on secretion, polyphosphoinositide hydrolysis and calcium mobilization in thrombin-stimulated human platelets. Biochem Biophys Res Commun 1986; 135: 1099-1104
    CrossrefPubMedGoogle Scholar
  • 12 Sage SO, Merritt JE, Hallam TJ, Rink TJ. Receptor-mediated calcium entry in fura-2-loaded human platelets stimulated with ADP and thrombin. Dual-wavelengths studies with Mn2+ . Biochem J 1989; 258: 923-926
    CrossrefPubMedGoogle Scholar
  • 13 Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37: 911-917
    CrossrefPubMedGoogle Scholar
  • 14 Zschauer A, van Breemen C, Bühler FR, Nelson MT. Calcium channels in thrombin-activated human platelet membrane. Nature (London) 1988; 334: 703-705
    CrossrefPubMedGoogle Scholar
  • 15 Kaibuchi K, Tsuda T, Kikuchi A, Tanimoto T, Takai Y. Enhancement of collagen-induced phosphoinositide turnover by thromboxane A2 analogue through Ca2+ mobilization in human platelets. FEBS Lett 1985; 192: 104-108
    CrossrefPubMedGoogle Scholar
  • 16 Brass LF, Joseph SK. A role for inositol triphosphate in intracellular Ca2+ mobilization and granule secretion in platelets. J Biol Chem 1985; 260: 15172-15179
    PubMedGoogle Scholar
  • 17 Daniel JL, Dangelmaier CA, Smith JB. Formation and metabolism of inositol 1,4,5-trisphosphate in human platelets. Biochem J 1987; 246: 109-114
    CrossrefPubMedGoogle Scholar
  • 18 Traver AP, King WG, Rittenhouse SE. Inositol 1,4,5-trisphosphate and inositol 1,2-cyclic 4,5-trisphosphate are minor components of total mass of inositol trisphosphate in thrombin-stimulated platelets. Rapid formation of inositol 1,3,4-trisphosphate. J Biol Chem 1987; 262: 17268-17271
    PubMedGoogle Scholar
  • 19 Houslay MD, Bojanic D, Wilson A. Platelet activating factor and U44069 stimulate a GTPase activity in human platelets which is distinct from the guanine nucleotide regulatory proteins, Ns and Ni. Biochem J 1986; 234: 737-740
    CrossrefPubMedGoogle Scholar
  • 20 Shenker A, Goldsmith P, Unson CG, Spiegel AM. The G protein coupled to the thromboxane A2 receptor in human platelets is a member of the novel Gq family. J Biol Chem 1991; 266: 9309-9313
    PubMedGoogle Scholar
  • 21 Taylor SJ, Chae HZ, Rhee SG, Exton JH. Activation of the β1 isozyme of phospholipase C by α subunits of the Gq class of G proteins. Nature (London) 1991; 350: 516-518
    CrossrefPubMedGoogle Scholar
  • 22 Takahara K, Murray R, FitzGerald GA, Fitzgerald DJ. The response to thromboxane A2 analogues in human platelets. Discrimination of two binding sites linked to distinct effector systems. J Biol Chem 1990; 265: 6836-6844
    PubMedGoogle Scholar
  • 23 Sage SO, Rink TJ. The kinetics of changes in intracellular calcium concentration in fura-2-loaded human platelets. J Biol Chem 1987; 262: 16364-16369
    PubMedGoogle Scholar
  • 24 Jones GD, Gear ARL. Subsecond calcium dynamics in ADP- and thrombin-stimulated platelets: A continuous-flow approach using Indo-1. Blood 1988; 71: 1539-1543
    PubMedGoogle Scholar
  • 25 Authi KS, Evenden BJ, Crawford N. Metabolic and functional consequences of introducing inositol 1,4,5-trisphosphate into saponin-permeabilized human platelets. Biochem J 1986; 233: 707-718
    CrossrefPubMedGoogle Scholar
  • 26 Werner MH, Hannun YA. Delayed accumulation of diacylglycerol in platelets as a mechanism for regulation of onset of aggregation and secretion. Blood 1991; 78: 435-444
    PubMedGoogle Scholar